ATE257384T1 - Verwendung von cilobradine oder pharmazeutisch akzeptablen salze zur behandlung oder prävention von herzversagen - Google Patents

Verwendung von cilobradine oder pharmazeutisch akzeptablen salze zur behandlung oder prävention von herzversagen

Info

Publication number: ATE257384T1
Authority: AT; Austria
Prior art keywords: cilobradine; treat; pharmaceutically acceptable; acceptable salts; heart failure
Prior art date: 2002-07-25

Application number

AT02016602T

Other languages

English (en)

Inventor

Brian Guth Dr

Randolf Seidler Dr

Juergen Daemmgen Dr

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-25

Filing date

2002-07-25

Publication date

2004-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29265956&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE257384(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-07-25 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2004-01-15 Application granted granted Critical

2004-01-15 Publication of ATE257384T1 publication Critical patent/ATE257384T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT02016602T 2002-07-25 2002-07-25 Verwendung von cilobradine oder pharmazeutisch akzeptablen salze zur behandlung oder prävention von herzversagen ATE257384T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02016602A EP1362590B1 (de)	2002-07-25	2002-07-25	Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen

Publications (1)

Publication Number	Publication Date
ATE257384T1 true ATE257384T1 (de)	2004-01-15

Family

ID=29265956

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT02016602T ATE257384T1 (de)	2002-07-25	2002-07-25	Verwendung von cilobradine oder pharmazeutisch akzeptablen salze zur behandlung oder prävention von herzversagen
AT03771064T ATE510543T1 (de)	2002-07-25	2003-07-21	Verwendung cilobradines oder seiner pharmazeutisch annehmbaren salze für die behandlung oder prävention von herzinsuffizienz

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT03771064T ATE510543T1 (de)	2002-07-25	2003-07-21	Verwendung cilobradines oder seiner pharmazeutisch annehmbaren salze für die behandlung oder prävention von herzinsuffizienz

Country Status (29)

Country	Link
US (1)	US20130317008A1 (de)
EP (2)	EP1362590B1 (de)
JP (3)	JP2005533853A (de)
KR (1)	KR20050074432A (de)
CN (1)	CN100502874C (de)
AR (1)	AR040690A1 (de)
AT (2)	ATE257384T1 (de)
AU (1)	AU2003254554B8 (de)
BR (1)	BR0312852A (de)
CA (1)	CA2493208C (de)
CO (1)	CO5700723A2 (de)
CY (1)	CY1112173T1 (de)
DE (1)	DE60200160T2 (de)
DK (2)	DK1362590T3 (de)
ES (2)	ES2211846T3 (de)
HR (1)	HRP20050075B1 (de)
MX (1)	MXPA05000617A (de)
MY (1)	MY128529A (de)
NZ (1)	NZ538424A (de)
PE (1)	PE20040706A1 (de)
PL (1)	PL214716B1 (de)
PT (2)	PT1362590E (de)
SA (1)	SA03240350B1 (de)
SI (2)	SI1362590T1 (de)
TR (1)	TR200400127T4 (de)
TW (1)	TWI319321B (de)
UY (1)	UY27910A1 (de)
WO (1)	WO2004011006A1 (de)
ZA (1)	ZA200500084B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2211846T3 (es) *	2002-07-25	2004-07-16	BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG	Uso de cilobradina o sus sales farmaceuticamente aceptables para el tratamiento o la prevencion de la insuficiencia cardiaca.
US20040138306A1 (en)	2002-07-25	2004-07-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
JPWO2007023775A1 (ja) *	2005-08-23	2009-02-26	アステラス製薬株式会社	心房細動治療剤
EP1762179A1 (de)	2005-09-07	2007-03-14	Boehringer Ingelheim Vetmedica Gmbh	Methode zur Verbesserung der Qualität der Diagnostik in der Echokardiographie
FR2894825B1 (fr) *	2005-12-21	2010-12-03	Servier Lab	Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2927538B1 (fr)	2008-02-14	2010-02-19	Servier Lab	Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
FR2961105B1 (fr) *	2010-06-15	2013-02-08	Servier Lab	Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
WO2013024036A1 (en)	2011-08-12	2013-02-21	Boehringer Ingelheim Vetmedica Gmbh	Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline
WO2014122248A1 (en)	2013-02-11	2014-08-14	Boehringer Ingelheim Vetmedica Gmbh	Kit-of-parts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3541811A1 (de) *	1985-11-27	1987-06-04	Thomae Gmbh Dr K	Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3736866A1 (de) *	1987-10-30	1989-05-11	Thomae Gmbh Dr K	Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3805635A1 (de) *	1988-02-24	1989-09-07	Thomae Gmbh Dr K	Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
US5760069A (en) *	1995-02-08	1998-06-02	Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1	Method of treatment for decreasing mortality resulting from congestive heart failure
JP4240173B2 (ja) *	1998-06-03	2009-03-18	日産化学工業株式会社	インダン誘導体
KR100664893B1 (ko) *	1999-06-03	2007-01-09	아스텔라스세이야쿠 가부시키가이샤	신규한 이소퀴놀린 유도체 또는 이의 염
DE10018401A1 (de) *	2000-04-13	2001-10-25	Boehringer Ingelheim Pharma	Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
ES2211846T3 (es) *	2002-07-25	2004-07-16	BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG	Uso de cilobradina o sus sales farmaceuticamente aceptables para el tratamiento o la prevencion de la insuficiencia cardiaca.

2002
- 2002-07-25 ES ES02016602T patent/ES2211846T3/es not_active Expired - Lifetime
- 2002-07-25 DK DK02016602T patent/DK1362590T3/da active
- 2002-07-25 SI SI200230008T patent/SI1362590T1/xx unknown
- 2002-07-25 EP EP02016602A patent/EP1362590B1/de not_active Expired - Lifetime
- 2002-07-25 TR TR2004/00127T patent/TR200400127T4/xx unknown
- 2002-07-25 PT PT02016602T patent/PT1362590E/pt unknown
- 2002-07-25 AT AT02016602T patent/ATE257384T1/de active
- 2002-07-25 DE DE60200160T patent/DE60200160T2/de not_active Expired - Lifetime
2003
- 2003-07-21 SI SI200332021T patent/SI1534296T1/sl unknown
- 2003-07-21 AU AU2003254554A patent/AU2003254554B8/en not_active Ceased
- 2003-07-21 PT PT03771064T patent/PT1534296E/pt unknown
- 2003-07-21 JP JP2004523757A patent/JP2005533853A/ja active Pending
- 2003-07-21 KR KR1020057001298A patent/KR20050074432A/ko not_active Application Discontinuation
- 2003-07-21 BR BR0312852-0A patent/BR0312852A/pt active Pending
- 2003-07-21 AT AT03771064T patent/ATE510543T1/de active
- 2003-07-21 CN CNB03817829XA patent/CN100502874C/zh not_active Expired - Fee Related
- 2003-07-21 EP EP03771064A patent/EP1534296B1/de not_active Expired - Lifetime
- 2003-07-21 PL PL372993A patent/PL214716B1/pl unknown
- 2003-07-21 DK DK03771064.7T patent/DK1534296T3/da active
- 2003-07-21 NZ NZ538424A patent/NZ538424A/en not_active IP Right Cessation
- 2003-07-21 WO PCT/EP2003/007929 patent/WO2004011006A1/en active Application Filing
- 2003-07-21 ES ES03771064T patent/ES2367109T3/es not_active Expired - Lifetime
- 2003-07-21 CA CA2493208A patent/CA2493208C/en not_active Expired - Fee Related
- 2003-07-21 MX MXPA05000617A patent/MXPA05000617A/es active IP Right Grant
- 2003-07-23 MY MYPI20032768A patent/MY128529A/en unknown
- 2003-07-24 PE PE2003000735A patent/PE20040706A1/es not_active Application Discontinuation
- 2003-07-24 TW TW092120260A patent/TWI319321B/zh not_active IP Right Cessation
- 2003-07-25 AR AR20030102678A patent/AR040690A1/es active Pending
- 2003-07-31 UY UY27910A patent/UY27910A1/es not_active Application Discontinuation
- 2003-10-19 SA SA03240350A patent/SA03240350B1/ar unknown
2005
- 2005-01-05 ZA ZA2005/00084A patent/ZA200500084B/en unknown
- 2005-01-24 HR HRP20050075AA patent/HRP20050075B1/hr not_active IP Right Cessation
- 2005-02-24 CO CO05017675A patent/CO5700723A2/es not_active Application Discontinuation
2009
- 2009-08-06 JP JP2009183392A patent/JP2009256379A/ja active Pending
2011
- 2011-08-24 CY CY20111100812T patent/CY1112173T1/el unknown
2013
- 2013-05-21 JP JP2013107160A patent/JP2013166781A/ja active Pending
- 2013-08-01 US US13/956,918 patent/US20130317008A1/en not_active Abandoned

Also Published As

Publication number	Publication date
UY27910A1 (es)	2004-02-27
KR20050074432A (ko)	2005-07-18
US20130317008A1 (en)	2013-11-28
AU2003254554B8 (en)	2009-02-26
CA2493208A1 (en)	2004-02-05
DE60200160D1 (de)	2004-02-12
AR040690A1 (es)	2005-04-13
PE20040706A1 (es)	2004-12-06
SA03240350B1 (ar)	2007-10-29
MY128529A (en)	2007-02-28
CA2493208C (en)	2011-11-01
PL372993A1 (en)	2005-08-08
TWI319321B (en)	2010-01-11
CN1671392A (zh)	2005-09-21
AU2003254554A1 (en)	2004-02-16
HRP20050075B1 (hr)	2013-12-20
NZ538424A (en)	2006-10-27
ZA200500084B (en)	2005-10-26
SI1534296T1 (sl)	2011-09-30
HRP20050075A2 (en)	2005-12-31
AU2003254554B2 (en)	2009-01-29
PL214716B1 (pl)	2013-09-30
CY1112173T1 (el)	2015-12-09
JP2013166781A (ja)	2013-08-29
PT1362590E (pt)	2004-05-31
TR200400127T4 (tr)	2004-02-23
WO2004011006A1 (en)	2004-02-05
EP1534296B1 (de)	2011-05-25
EP1362590A8 (de)	2004-02-25
DK1362590T3 (da)	2004-03-29
BR0312852A (pt)	2005-04-19
ES2367109T3 (es)	2011-10-28
TW200412974A (en)	2004-08-01
JP2005533853A (ja)	2005-11-10
ATE510543T1 (de)	2011-06-15
DK1534296T3 (da)	2011-08-15
ES2211846T3 (es)	2004-07-16
MXPA05000617A (es)	2005-08-19
CN100502874C (zh)	2009-06-24
SI1362590T1 (en)	2004-04-30
EP1362590A1 (de)	2003-11-19
PT1534296E (pt)	2011-08-18
JP2009256379A (ja)	2009-11-05
DE60200160T2 (de)	2004-11-04
EP1534296A1 (de)	2005-06-01
CO5700723A2 (es)	2006-11-30
EP1362590B1 (de)	2004-01-07

Publication	Publication Date	Title
ATE499105T1 (de)	2011-03-15	Behandlung oder vorbeugung von haut- oder gewebezuständen bei tieren unter verwendung von boryloxypyridylmethanonen
ATE414556T1 (de)	2008-12-15	Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten
ATE390407T1 (de)	2008-04-15	Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
IS8913A (is)	2010-07-21	Afleiður 4-tetrazólýl-4-fenýlpiperidíns til þess að meðhöndla verk
DE60328476D1 (de)	2009-09-03	Medizinisches ballonsystem zur behandlung von adipositas
DE50310980D1 (de)	2009-02-05	VERWENDUNG VON I kappa B-KINASE INHIBITOREN IN DER SCHMERZTHERAPIE
DE50306850D1 (de)	2007-05-03	Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen
DE602006010442D1 (de)	2009-12-24	Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen
ATE359087T1 (de)	2007-05-15	Verwendung von erythropoietin zur behandlung oder vorbeugung von herzversagen
ATE257384T1 (de)	2004-01-15	Verwendung von cilobradine oder pharmazeutisch akzeptablen salze zur behandlung oder prävention von herzversagen
ATE429916T1 (de)	2009-05-15	Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
DE602004022035D1 (de)	2009-08-27	Verwendung von pthalide derivativen zur behandlung
ATE380558T1 (de)	2007-12-15	Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
DE602005014145D1 (de)	2009-06-04	Medikamente zur behandlung oder prävention fibrotischer krankheiten
DE60314003D1 (de)	2007-07-05	4-(phenylpiperazinylmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen oder gastrointestinalen erkrankungen
ATE410169T1 (de)	2008-10-15	Verwendung eines phenothiazin-derivats zur prävention und/oder behandlung von gerhörverlust
ATE551052T1 (de)	2012-04-15	Verwendung von reninhemmern zur prävention oder behandlung von diastolischer dysfunktion oder diastolischer herzinsuffizienz
ATE516040T1 (de)	2011-07-15	Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis
ATE487480T1 (de)	2010-11-15	Perhexilin zur behandlung von chronischer herzinsuffizienz
ATE330596T1 (de)	2006-07-15	Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE602006020838D1 (de)	2011-05-05	Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
ATE376416T1 (de)	2007-11-15	Verwendung von ambroxol zur behandlung von chronischen schmerzen
DE602004012770D1 (de)	2008-05-08	Saure chinolin-derivate und ihre verwendung zur prävention und/oder behandlung von erkrankungen im zusammenhang mit hyperglykämie
ATE359270T1 (de)	2007-05-15	Phenyl-piperidin-4-yliden-methyl-benzamidderiva e zur behandlung von schmerz oder magen-darm- erkrankungen
DE60333742D1 (de)	2010-09-23	Verwendung einer kombination von l-carnitin, acetyl l-carnitin und propionyl l-carnitin zur behandlung von oligoasthenoteratospermia

Legal Events

Date	Code	Title	Description
2004-09-15	UEP	Publication of translation of european patent specification	Ref document number: 1362590 Country of ref document: EP

Date

Code

Title

Description

2004-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1362590

Country of ref document: EP